Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010

Eurosurveillance

Volumn 15, Issue 17, 2010, Pages 11-14

  Whelan, J ^a,b   van Binnendijk, R ^a   Greenland, K ^a,b   Fanoy, E ^a,c   Khargi, M ^d   Yap, K ^e   Boot, H ^a   Veltman, N ^a   Swaan, C ^a   van der Bij, A ^a   de Melker, H ^a   Hahne S ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c Municipal Health Service   (Netherlands)

^d Municipal Health Service   (Netherlands)

^e Municipal Health Service   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; MUMPS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; EPIDEMIC; FEMALE; GENOTYPING TECHNIQUE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MUMPS; MUMPS VIRUS; NETHERLANDS; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; STUDENT; SYMPTOM; VACCINATION; HEALTH SURVEY; MASS IMMUNIZATION; METHODOLOGY; RISK ASSESSMENT; STATISTICS; UTILIZATION REVIEW;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; INCIDENCE; MALE; MASS VACCINATION; MUMPS; MUMPS VACCINE; NETHERLANDS; POPULATION SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS; STUDENTS; YOUNG ADULT;

EID: 77952715737     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.15.17.19554-en     Document Type: Article

References (18)

1. Parotitis epidemica: Bof (Mumps) B26. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2009. [Accessed 12 April 2010]. Available from: http://www.rivm.nl/cib/infectieziekten-A-Z/infectieziekten/Parotitis_epidemica/index.jsp. Dutch.
2. Karagiannis I, van Lier A, van Binnendijk R, Ruijs H, Fanoy E, Conyn-Van Spaendonck M, et al. Mumps in a community with low vaccination coverage in the Netherlands. Eurosurveillance. 2010;12(13).pii:18901. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18901
3. van Lier E, Oomen P, Oostenburg M, Zwakhals S, Drijfhout I, de Hoogh P, et al. Vaccinatiegraad Rijksvaccinatieprogramma Nederland. Verslagjaar 2009. [National Immunisation Programme in the Netherlands. Annual Report 2009]. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2009. Available from: http://www.rivm.nl/bibliotheek/rapporten/210021010.pdf
4. Brockhoff HJ, Mollema L, Sonder GJ, Postema CA, van Binnendijk RS, Kohl RH, et al. Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine. 2010;9;28(17):2932-6.
5. Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis. 2008;47(11):1458-67.
6. Stein-Zamir C, Shoob H, Abramson N, Tallen-Gozani E, Sokolov I, Zentner G. Mumps outbreak in Jerusalem affecting mainly male adolescents. Euro Surveill. 2009;14(50). pii=19440. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19440
7. Schwarz NG, Bernard H, Melnic A, Bucov V, Caterinciuc N, Ander Heiden M, et al. Mumps Outbreak in the Republic of Moldova, 2007-2008. Pediatr Infect Dis J. 2010 Mar 19. [Epub ahead of print].
8. Briss PA, Fehrs LJ, Parker RA, Wright PF, Sannella EC, Hutcheson RH, et al. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis. 1994;169(1):77-82.
9. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis. 2007;13(1):12-7.
10. Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis. 2008;46(8):1172-80.
11. Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis. 2007;45(4):459-66.
12. Centers for Disease Control and Prevention (CDC). Update: Mumps Outbreak - New York and New Jersey, June 2009-January 2010. MMWR Morb Mortal Wkly Rep. 2010;12;59(5):125-9.
13. Whyte D, O'Dea F, McDonnell C, O'Connell NH, Callinan S, Brosnan E, et al. Mumps epidemiology in the mid-west of Ireland 2004-2008: increasing disease burden in the university/college setting. Euro Surveill. 2009;14(16).pii=19182. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19182
14. Huang AS, Cortese MM, Curns AT, Bitsko RH, Jordan HT, Soud F, et al. Risk factors for mumps at a university with a large mumps outbreak. Public Health Rep. 2009;124(3):419-26.
15. World Health Organisation. Mumps Virus Vaccines. Wkly Epidemiol Rec. 2007;82(7):51-60.
16. Inspectie voor de gezondheidszorg. [Inspectorate for Health]. Vaccinatietoestand Nederland per 1 januari 2003: Rapport. [Vaccination in the Netherlands as of 1 January 2003: Report]. The Hague: Staatstoezicht op de Volksgezondheid [State Supervision of Public Health]; 2004. Available at: http://www.rivm.nl/bibliotheek/rapporten/210021001.pdf
17. van den Hof S, Beaumont MT, Berbers GA, de Melker HE. Antibodies against mumps in The Netherlands as assessed by indirect ELISA and virus neutralization assay. Epidemiol Infect. 2003;131(1):703-9.
18. Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ, et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis. 2008;198(4):508-15.